Who We Are

About Us 

Tawam Molecular Imaging Centre (TMIC) is a specialized molecular imaging Centre in Al Ain providing advanced PET/CT imaging services across oncology, cardiology, and neurology. Our Centre brings together advanced imaging technology, specialized clinical expertise, and on-site radiopharmaceutical production to support physicians in diagnosis, treatment planning, and monitoring. 

At TMIC, we recognize that every imaging examination begins with a clinical question. Our services are designed to provide referring physicians with relevant molecular and functional information that can complement other diagnostic investigations and support clinical decision-making. From radiopharmaceutical preparation and quality control to imaging and clinical interpretation, our integrated approach brings multiple aspects of the molecular imaging pathway together within one Centre. 

Central to our services is PET/CT, which combines two complementary imaging techniques in a single examination. PET provides information about metabolic and molecular activity within the body, while CT provides detailed anatomical information. CT also helps localize areas of interest identified on PET and provides the structural context needed to understand these findings. Together, these technologies provide information about both biological activity and anatomical location, supporting the clinical evaluation of selected conditions. 

For patients, this means access to specialized PET/CT and molecular imaging services in Al Ain, supported by a team committed to providing clear guidance throughout the imaging journey. From preparation and radiopharmaceutical administration to the completion of the examination, our team works to help patients understand what to expect at each stage of their visit. Our advanced PET/CT imaging capabilities provide detailed 3D images that bring together anatomical and physiological information, providing physicians with relevant information for the clinical question being investigated. Whether you are seeking specialized molecular imaging or have been referred for a PET/CT examination, the TMIC team is here to support you throughout your imaging journey. 

An Integrated Approach to Molecular Imaging

Molecular imaging brings together advanced imaging technology, specialized radiopharmaceuticals, and clinical expertise to provide information that can complement conventional diagnostic investigations. At TMIC, these capabilities are connected within an integrated environment, linking radiopharmaceutical production and quality control with specialized PET/CT imaging. Our on-site capabilities allow key stages of the molecular imaging pathway to be supported within the same Centre, from the production and preparation of radiopharmaceuticals through quality control and clinical imaging. This integrated model supports the delivery of specialized examinations according to the clinical question being investigated and the information required by the referring physician. 

By bringing dedicated infrastructure and multidisciplinary knowledge together, TMIC supports a range of molecular imaging applications while maintaining a coordinated approach to the imaging pathway. This integrated environment also allows the Centre to provide specialized molecular imaging services closer to patients and referring physicians in Al Ain. 

Specialized Clinical Expertise

Our clinical services are supported by healthcare professionals with specialized experience in nuclear medicine and molecular imaging. The team provides expertise across a range of applications, including oncologic imaging, precision oncology, prostate cancer molecular imaging, neuroendocrine tumour imaging, neurodegenerative and dementia imaging, and other specialized molecular imaging applications.

TMIC also provides specialized cardiac PET/CT services, including cardiac amyloid imaging, alongside neurological and oncological molecular imaging applications. The appropriate examination and radiopharmaceutical are selected according to the patient’s clinical indication, medical history, previous investigations, and the clinical question being addressed. The breadth of clinical expertise at TMIC reflects the diverse applications of molecular imaging. Depending on the clinical question and radiopharmaceutical used, PET/CT may provide information about tumor biology, myocardial perfusion, brain metabolism, or specific molecular targets. This allows imaging examinations to be selected according to the information required by the referring physician and the needs of the individual patient. 

Technology and Integrated Radiopharmacy 

Advanced PET/CT imaging depends not only on the imaging system itself, but also on the availability, preparation, and quality of the radiopharmaceuticals used during an examination. TMIC operates an on-site cyclotron and radiopharmacy facility supported by dedicated production and quality-control systems. 

The Centre’s radiopharmacy capabilities include the production and preparation of multiple radiopharmaceuticals for clinical applications in oncology, cardiology, and neurology. The facility includes a Siemens Eclipse HP cyclotron, shielded hot cells, radiopharmaceutical synthesis equipment, and a dedicated quality-control laboratory. By bringing radiopharmaceutical production, preparation, quality control, and PET/CT imaging together within one Centre, TMIC supports an integrated molecular imaging pathway. This infrastructure also supports the availability of specialized radiopharmaceuticals for different clinical applications, according to the Centre’s capabilities and applicable requirements. 

Our Role in the Imaging Journey

Molecular imaging can form an important part of the wider diagnostic pathway, providing additional information when conventional investigations alone may not fully answer the clinical question. At TMIC, our role extends across key stages of the molecular imaging pathway, from supporting the availability of appropriate radiopharmaceuticals to delivering specialized PET/CT examinations.

Our services are designed to provide referring physicians with relevant molecular, functional, and anatomical imaging information that can complement other clinical and diagnostic findings. The information obtained through PET/CT is considered alongside the patient’s clinical history, symptoms, previous investigations, and other relevant diagnostic information. By bringing specialized imaging expertise, advanced PET/CT capabilities, and integrated radiopharmacy services together, TMIC supports patients and referring physicians throughout the molecular imaging pathway. Through this approach, the Centre provides access to specialized molecular imaging services for patients in Al Ain and the surrounding region.